NCT03648840

Brief Summary

Prolonged alcohol use results in drinking despite resultant problems and adverse consequences. The investigators propose to test a laboratory model of human seeking despite aversion to use as an early marker of disease onset, and as a tool for study of its neural functional substrates, and identification of effective treatments.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 27, 2018

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2022

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

February 25, 2025

Completed
Last Updated

February 25, 2025

Status Verified

February 1, 2025

Enrollment Period

4.1 years

First QC Date

August 21, 2018

Results QC Date

October 2, 2024

Last Update Submit

February 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Effect of Exposure to Aversive Cues on IV Alcohol Self-administration

    Participants earn 2.5 min exposures to an increase in iv infusion rate (causing a prescribed increase in breath alcohol concentration (BRAC)) by completing repetitions of a constant attention button-pressing task (CAT). The task is designed so that the number of correct CAT trials required increases progressively from 1 (for the first drink) to 380 (for the 20th drink) on an accelerating scale. The dependent measure Breakpoint is defined as the cumulative number of correct and incorrect CAT trials completed when the last drink is earned; in the time allowed possible values ranged from 1 to 800. Effect of the Aversive cue was assessed by calculating a difference score (Breakpoint Aversive Cue-Breakpoint Neutral Cue); the range of possible difference scores was -800 to +800. A positive difference score indicates a higher breakpoint (more alcohol earned) in the Aversive Cue session; a negative number indicates a lower breakpoint (less alcohol earned).

    In two infusion sessions, to occur 5-14 days apart

Study Arms (2)

Higher lifetime alcohol drinking

EXPERIMENTAL

Participants with a history of higher lifetime alcohol consumption

Behavioral: Aversive CueBehavioral: Neutral Cue

Lower lifetime alcohol drinking

EXPERIMENTAL

Participants with a lower lifetime alcohol consumption

Behavioral: Aversive CueBehavioral: Neutral Cue

Interventions

Aversive CueBEHAVIORAL

Participants will be exposed to unpleasant pictures and tones during performance of a task to earn alcohol

Higher lifetime alcohol drinkingLower lifetime alcohol drinking
Neutral CueBEHAVIORAL

Participants will be exposed to neutral pictures and tones during performance of a task to earn alcohol

Higher lifetime alcohol drinkingLower lifetime alcohol drinking

Eligibility Criteria

Age21 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men and women age 21-55
  • Range of lifetime alcohol drinking history from 25 kg to 500 kg, with preference for extremes, plus recent drinking at least 7 drinks/week (women) and 20 drinks/week (men)
  • Able to understand and complete questionnaires and procedures in English
  • Willing and able to tolerate iv placement
  • Right-handed (for fMRI Arm only)

You may not qualify if:

  • Pregnant or breast-feeding
  • Seeking or in treatment for substance use disorder or under court ordered abstinence
  • Medications, medical disorders or conditions that could affect study outcome or subject safety
  • Positive urine drug screen for amphetamines/methamphetamines, barbiturates, benzodiazepines, cocaine, opiates, or phencyclidine
  • Positive breath alcohol (BrAC) reading on arrival at any study visit
  • Actively suicidal (within previous year)
  • Left-handed or ambidextrous (for fMRI Arm only)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Indianapolis, Indiana, 46202, United States

Location

Related Publications (1)

  • Garrison ACS, Wu W, Cox MR, Haines D, Hays J, Mlungwana MK, Kosobud AEK, Kareken DA, O'Connor S, Plawecki MH, Cyders MA. Aversion-resistant alcohol seeking in the human laboratory. Alcohol Clin Exp Res (Hoboken). 2025 Jul;49(7):1518-1529. doi: 10.1111/acer.70078. Epub 2025 Jul 6.

MeSH Terms

Conditions

Alcoholism

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Results Point of Contact

Title
Dr. Martin H. Plawecki, MD, PhD
Organization
Indiana University - Indianapolis

Study Officials

  • Martin H Plawecki, MD, PhD

    Psychiatry, Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Melissa A Cyders, PhD

    Psychology, Indiana University-Purdue University at Indianapolis

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Subjects are not informed which session will include aversive cues.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: 2 session crossover, random order, single blind
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychiatry

Study Record Dates

First Submitted

August 21, 2018

First Posted

August 27, 2018

Study Start

April 4, 2018

Primary Completion

May 4, 2022

Study Completion

May 4, 2022

Last Updated

February 25, 2025

Results First Posted

February 25, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

After publication of the main findings, a de-identified dataset will be made available through direct requests as described above; a statement to this effect will be included in all published manuscripts. The current proposal utilizes the Seeking Despite Aversion Task, a newly developed Computer-Assisted Infusion System (CAIS) protocol that integrates delivery of visual stimuli into the Constant Attention Task and optical markers for evoked response potential generation. This task, like other CAIS protocols, will become part of the portfolio of CAIS programs that our lab makes available to other scientists once our specific funded use of this protocol is completed. Modified versions of this protocol could be provided to other investigators prior to completion of this project as long as these projects do not directly compete.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will become available following final publication of all manuscripts by the component investigators. Earliest date is estimated to be January, 2025.
Access Criteria
Data and Resource Sharing Plan - Indiana Alcohol Research Center (IARC) Consistent with its past history, the IARC continues to make available its data and resources to investigators engaged in alcoholism research outside of Indiana University. Detailed procedures are available on request. In brief, investigators must submit a written request specifying in adequate detail the specific resource(s) required and a study protocol indicating the specific aims, scientific rationale, methods and procedure, and analysis of results; a signed IARC Resource Utilization Agreement Form; and for studies involving human subjects, Institutional Review Board (IRB) approval if needed for the proposed study. The request will be reviewed by the IARC Steering Committee. Investigators must agree to acknowledge the Indiana Alcohol Research Center (P60 AA007611) as the source of the resource in all resulting publications.

Locations